Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase NA 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer NSCLC 1Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Liver Diseases 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT01180751 2013-08-15

18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology

University of Manitoba

Phase 3 Unknown
1,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡